Evidence map›Paper›PMID 20557315›Full record

ArticleCellular microbiology2010

Activation of brain endothelium by pneumococcal neuraminidase NanA promotes bacterial internalization.

Anirban Banerjee, Nina M Van Sorge, Tamsin R Sheen, Satoshi Uchiyama, Tim J Mitchell, Kelly S Doran

Open access · bronzeAbstract read
In one paragraph

Article in Cellular microbiology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
3.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 78 citations in OpenAlex.

  1. Article
  2. Review
  3. Frontiers in cellular and infection microbiology · 2025
    Review
  4. Review
  5. Frontiers in cellular and infection microbiology · 2022
    Review
  6. Article
  7. Article
  8. Pneumococcal Encounter With the Blood-Brain Barrier Endothelium.Frontiers in cellular and infection microbiology · 2020
    Review
  9. Article
  10. Article
  11. Microbiology spectrum · 2019
    Review
  12. Article
  13. Article
  14. Sialidases FromFrontiers in cellular and infection microbiology · 2019
    Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. mBio · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Anirban BanerjeeDepartment of Biology, Center for Microbial Sciences, San Diego State University, San Diego, CA, USA.
Nina M Van Sorge
Tamsin R Sheen
Satoshi Uchiyama
Tim J Mitchell
Kelly S Doran
University of California, San Diego · USUniversity of Glasgow · GB

Funding

Blood-brain barrier in bacterial meningitisR01NS051247 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DORAN, KELLY S · 2006 to 2015
$3.2M
NINDS NIH HHS R01 NS051247NINDS NIH HHS R01NS051247
6 · The paper itself

Abstract

Streptococcus pneumoniae (SPN), the leading cause of meningitis in children and adults worldwide, is associated with an overwhelming host inflammatory response and subsequent brain injury. Here we examine the global response of the blood-brain barrier to SPN infection and the role of neuraminidase A (NanA), an SPN surface anchored protein recently described to promote central nervous system tropism. Microarray analysis of human brain microvascular endothelial cells (hBMEC) during infection with SPN or an isogenic NanA-deficient (ΔnanA) mutant revealed differentially activated genes, including neutrophil chemoattractants IL-8, CXCL-1, CXCL-2. Studies using bacterial mutants, purified recombinant NanA proteins and in vivo neutrophil chemotaxis assays indicated that pneumococcal NanA is necessary and sufficient to activate host chemokine expression and neutrophil recruitment during infection. Chemokine induction was mapped to the NanA N-terminal lectin-binding domain with a limited contribution of the sialidase catalytic activity, and was not dependent on the invasive capability of the organism. Furthermore, pretreatment of hBMEC with recombinant NanA protein significantly increased bacterial invasion, suggesting that NanA-mediated activation of hBMEC is a prerequisite for efficient SPN invasion. These findings were corroborated in an acute murine infection model where we observed less inflammatory infiltrate and decreased chemokine expression following infection with the ΔnanA mutant.

Indexed as

AnimalsBlood-Brain BarrierBrainChemokine CCL20Chemokine CXCL1Chemokine CXCL2Chemotaxis, LeukocyteEndothelial CellsEndothelium, VascularGene Expression ProfilingHumansInterleukin-8LectinsMeningitis, PneumococcalMiceMutationChemokine CCL20Chemokine CXCL1Chemokine CXCL2Interleukin-8LectinsNeuraminidase

Identifiers

PMID20557315
PMCPMC2943548
OpenAlexW1579318101

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.